Meropenem monotherapy was as effective as imipenem/cilastatin in 4 comparative trials in terms of satisfactory clinical and bacteriological responses.

• 依据临床满意度和细菌学反应，美罗培南硫化物在4组临床比较试验中拥有与亚胺培南一样的效用。